Skip to main content

Screening’s partnership work with Sickle Cell Society benefits people with sickle cell disorders

Posted by: , Posted on: - Categories: NHS Sickle Cell and Thalassaemia Screening Programme
Two women talking and laughing with John James, chief executive of Sickle Cell Society
The Sickle Cell Society won a 2018 GSK Impact Award in partnership with the King's Fund for its work in offering services at a community level and influencing national policy

At the Sickle Cell Society we are passionate about making a difference to the lives of people who live with sickle cell disorders and their families. Patients and their families are at the heart of our work and are essential to the decisions we make as a charity.

Having a patient focus can be very hard work but it is very rewarding. Last year we won a 2018 GSK Impact Award in partnership with the King's Fund, beating competition from more than 350 organisations from all over the UK.

An important part of our work has been in partnership with the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme. We have built a strong and lasting relationship with the national programme built on trust and a joint passion to put patients at the centre of our work.

Patient organisations add value and make positive impact

I would like to focus on the value of this partnership work and what it can achieve. It recently resulted in the joint publication between myself and Dr Elizabeth Dormandy, until recently a part of the national PHE screening team, of a paper in the International Journal of Neonatal Screening – a well respected publication aimed at European haematologists, clinicians and other stakeholders who have an interest in haemoglobinopathies.

The paper, Improving Screening Programmes for Sickle Cell Disorders and Other Haemoglobinopathies in Europe: The Role of Patient Organisations, describes the unique contribution and added value that patient organisations can give to the development and improvement of screening programmes in partnership with statutory bodies.

I would like to say a big thank you to Dr Dormandy, Dr Jacques Elion (Professor at Université Paris Diderot – Sorbonne Paris Cité), our NHS engagement lead Iyamide Thomas and national NHS SCT Screening Programme Manager Cathy Coppinger for all their hard work in making this partnership such a success.

It is refreshing to see professionals in both the UK and Europe understanding the importance of partnership and the positive impact it can have. I hope we will continue to see more partnerships forming to improve patient care across Europe and the World.

For more information about the Sickle Cell Society you can follow us on Facebook (@SickleCellUK), Twitter (@SickleCellUK) and Instagram (sicklecelluk).

PHE Screening blogs

PHE Screening blogs provide up to date news from all NHS screening programmes. You can register to receive updates direct to your inbox, so there’s no need to keep checking for new blogs. If you have any questions about this blog article, or about population screening in England, please contact the PHE screening helpdesk.

Sharing and comments

Share this page